Left ventricular geometry in obesity: Is it what we expect?

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 10, 2013, Pages 905-912

  de Simone, G ^a   Izzo, R ^a   De Luca, N ^a   Gerdts, E ^a,b  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Allometric signal; Body composition; Body size; Cardiac geometry; Cardiac workload

Indexed keywords

BLOOD PRESSURE; BODY MASS; CARDIOMYOPATHY; DISEASE ASSOCIATION; GENDER; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HEMODYNAMIC STRESS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PLASMA RENIN ACTIVITY; PREVALENCE; REVIEW; WEIGHT REDUCTION;

ALLOMETRIC SIGNAL; BODY COMPOSITION; BODY SIZE; CARDIAC GEOMETRY; CARDIAC WORKLOAD;

BODY SIZE; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MODELS, BIOLOGICAL; OBESITY; PREVALENCE; SEX CHARACTERISTICS; WEIGHT LOSS;

EID: 84886298272     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.06.012     Document Type: Review

References (93)

1. Forbes G.B., Welle S.L. Lean body mass in obesity. Int J Obes 1983, 7:99-107.
2. Stenholm S., Harris T.B., Rantanen T., Visser M., Kritchevsky S.B., Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008, 11:693-700.
3. Lyon C.J., Law R.E., Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003, 144:2195-2200.
4. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
5. Tentolouris N., Liatis S., Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2006, 1083:129-152.
6. de Simone G., Devereux R.B., Kizer J.R., Chinali M., Bella J.N., Oberman A., et al. Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN study. Am J Clin Nutr 2005, 81:757-761.
7. Collis T., Devereux R.B., Roman M.J., de Simone G., Yeh J., Howard B.V., et al. Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 2001, 103:820-825.
8. de Simone G., Devereux R.B., Kimball T.R., Mureddu G.F., Roman M.J., Contaldo F., et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998, 31:1077-1082.
9. Bella J.N., Devereux R.B., Roman M.J., O'Grady M.J., Welty T.K., Lee E.T., et al. Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 1998, 98:2538-2544.
10. de Simone G., Devereux R.B., Roman M.J., Alderman M.H., Laragh J.H. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994, 23:600-606.
11. Chinali M., de Simone G., Roman M.J., Lee E.T., Best L.G., Howard B.V., et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the strong heart study. J Am Coll Cardiol 2006, 47:2267-2273.
12. Woodruff S.J., Fryer K., Campbell T., Cole M. Associations among blood pressure, salt consumption and body weight status of students from south-western Ontario. Public Health Nutr 2013, 1-6.
13. Grimes C.A., Riddell L.J., Campbell K.J., Nowson C.A. Dietary salt intake, sugar-sweetened beverage consumption, and obesity risk. Pediatrics 2013, 131:14-21.
14. du Cailar G., Ribstein J., Daures J.P., Mimran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 1992, 263:H177-H181.
15. Alves-Rodrigues E.N., Veras M.M., Rosa K.T., de Castro I., Furukawa L.N., Oliveira I.B., et al. Salt intake during pregnancy alters offspring's myocardial structure. Nutr Metab Cardiovasc Dis 2013, 23:481-486.
16. Licata G., Volpe M., Scaglione R., Rubattu S. Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 1994, 23:I20-I24.
17. Facchini F.S., DoNascimento C., Reaven G.M., Yip J.W., Ni X.P., Humphreys M.H. Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion. Hypertension 1999, 33:1008-1012.
18. Strazzullo P., D'Elia L., Kandala N.B., Cappuccio F.P. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009, 339:b4567. 10.1136/bmj.b4567.
19. Rodrigues S.L., Baldo M.P., Mill J.G. Association of waist-stature ratio with hypertension and metabolic syndrome: population-based study. Arq Bras Cardiol 2010, 95:186-191.
20. Leichman J.G., Lavis V.R., Aguilar D., Wilson C.R., Taegtmeyer H. The metabolic syndrome and the heart-a considered opinion. Clin Res Cardiol 2006, 95(Suppl. 1):i134-i141.
21. Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A., Langenbach J., Willenberg H.S., Barthel A., et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003, 100:14211-14216.
22. Schrier R.W., Masoumi A., Elhassan E. Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol 2010, 5:1132-1140.
23. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991, 14:1132-1143.
24. Ferrara L.A., Mancini M., de Simone G., Pisanti N., Capone D., Fasano M.L., et al. Adrenergic nervous system and left ventricular mass in primary hypertension. Eur Heart J 1989, 10:1036-1040.
25. Verdecchia P., Reboldi G., Schillaci G., Borgioni C., Ciucci A., Telera M.P., et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999, 100:1802-1807.
26. de Simone G., Devereux R.B., Palmieri V., Roman M.J., Celentano A., Welty T.K., et al. Relation of insulin resistance to markers of preclinical cardiovascular disease: the strong heart study. Nutr Metab Cardiovasc Dis 2003, 13:140-147.
27. Wong C.Y., O'Moore-Sullivan T., Leano R., Byrne N., Beller E., Marwick T.H. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004, 110:3081-3087.
28. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004, 94:1084-1087.
29. Szczepaniak L.S., Victor R.G., Orci L., Unger R.H. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007, 101:759-767.
30. Niemann B., Chen Y., Teschner M., Li L., Silber R.E., Rohrbach S. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 2011, 57:577-585.
31. Rider O.J., Petersen S.E., Francis J.M., Ali M.K., Hudsmith L.E., Robinson M.R., et al. Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity. Heart 2011, 97:203-208.
32. Celentano A., Palmieri V., Esposito N.D., Pietropaolo I., Crivaro M., Mureddu G.F., et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001, 87:361-363.
33. Shin J., Lee J.U., Kim K.S., Kim S.G., Kim J.H., Lim H.K., et al. Influence of abdominal circumference on the inappropriateness of left ventricular mass and diastolic function in non-obese patients. J Cardiol 2007, 49:323-329.
34. Avelar E., Cloward T.V., Walker J.M., Farney R.J., Strong M.H., Pendleton R.C., et al. Left ventricular hypertrophy in severe obesity: interactions between systolic blood pressure, nocturnal hypoxemia and increasing body mass. Hypertension 2007, 49:34-39.
35. de Simone G., Palmieri V., Bella J.N., Celentano A., Hong Y., Oberman A., et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 2002, 20:323-331.
36. Thomas F., Bean K., Pannier B., Oppert J.M., Guize L., Benetos A. Cardiovascular mortality in overweight subjects: the key role of associated risk factors. Hypertension 2005, 46:654-659.
37. de Simone G., Devereux R.B., Chinali M., Roman M.J., Best L.G., Welty T.K., et al. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the strong heart study. Hypertension 2006, 47:162-167.
38. Dewey F.E., Rosenthal D., Murphy D.J., Froelicher V.F., Ashley E.A. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation 2008, 117:2279-2287.
39. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992, 20:1251-1260.
40. Urbina E.M., Gidding S.S., Bao W., Pickoff A.S., Berdusis K., Berenson G.S. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa heart study. Circulation 1995, 91:2400-2406.
41. Stahl W.R., Gummerson J.Y. Systematic allometry in five species of adult primates. (Systematic allometry in primates). Growth 1967, 31:21-34.
42. Schmidt-Nielsen K. Scaling in biology: the consequences of size. J Exp Zool 1975, 194:287-307.
43. Lauer M.S., Anderson K.M., Larson M.G., Levy D. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 1994, 74:487-491.
44. Chirinos J.A., Segers P., de Buyzere M.L., Kronmal R.A., Raja M.W., De B.D., et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 2010, 56:91-98.
45. de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., Laragh J.H. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056-1062.
46. Daniels S.R., Kimball T.R., Morrison J.A., Khoury P., Meyer R.A. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 1995, 76:699-701. [see comments].
47. de Simone G., Kizer J.R., Chinali M., Roman M.J., Bella J.N., Best L.G., et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the strong heart study. Am J Hypertens 2005, 18:191-196.
48. Liao Y., Cooper R.S., Durazo-Arvizu R., Mensah G.A., Ghali J.K. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997, 29:641-647. [see comments].
49. de Simone G., Devereux R.B. Method errors or unexplained biological information?. Hypertension 2010, 56:e177-e178.
50. Chirinos J.A., Gillebert T.C., Segers P., de Buyzere M.L., Kronmal R., Raja M.W., et al. Response to method errors or unexplained biological information?. Hypertension 2011, 57:e9-10.
51. McCarron P., Okasha M., McEwen J., Smith G.D. Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. Am J Epidemiol 2002, 155:683-687.
52. Jousilahti P., Tuomilehto J., Vartiainen E., Eriksson J., Puska P. Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle-aged men and women in Finland. Am J Epidemiol 2000, 151:1112-1120.
53. Paajanen T.A., Oksala N.K., Kuukasjarvi P., Karhunen P.J. Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J 2010, 31:1802-1809.
54. Lavie C.J., Milani R.V., Ventura H.O., Cardenas G.A., Mehra M.R., Messerli F.H. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007, 100:1460-1464.
55. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558. [see comments].
56. de Simone G. Concentric or eccentric hypertrophy: how clinically relevant is the difference?. Hypertension 2004, 43:714-715.
57. Woodiwiss A.J., Libhaber C.D., Majane O.H., Libhaber E., Maseko M., Norton G.R. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens 2008, 21:1144-1151.
58. Chinali M., Aurigemma G.P. Refining patterns of left ventricular hypertrophy using cardiac MRI: "brother, can you spare a paradigm?". Circ Cardiovasc Imaging 2010, 3:129-131.
59. Lund B.P., Gohlke-Barwolf C., Cramariuc D., Rossebo A.B., Rieck A.E., Gerdts E. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a simvastatin ezetimibe in aortic stenosis [SEAS] substudy). Am J Cardiol 2010, 105:1456-1460.
60. Turkbey E.B., McClelland R.L., Kronmal R.A., Burke G.L., Bild D.E., Tracy R.P., et al. The impact of obesity on the left ventricle: the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging 2010, 3:266-274.
61. Comley K., Fleck N.A. A micromechanical model for the Young's modulus of adipose tissue. Int J Solids and Structures 2010, 47:2982-2990.
62. Ezure T., Amano S. Influence of subcutaneous adipose tissue mass on dermal elasticity and sagging severity in lower cheek. Skin Res Technol 2010, 16:332-338.
63. McGavock J.M., Victor R.G., Unger R.H., Szczepaniak L.S. Adiposity of the heart, revisited. Ann Intern Med 2006, 144:517-524.
64. Bo S., Mandrile C., Milanesio N., Pagani A., Gentile L., Gambino R., et al. Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study. Nutr Metab Cardiovasc Dis 2012, 22:668-676.
65. Malavazos A.E., Corsi M.M., Ermetici F., Coman C., Sardanelli F., Rossi A., et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007, 17:294-302.
66. Lopez B., Castellano J.M., Gonzalez A., Barba J., Diez J. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension 2007, 50:977-983.
67. de Simone G., Devereux R.B., Chinali M., Best L.G., Lee E.T., Welty T.K. Association of blood pressure with blood viscosity in American Indians. The strong heart study. Hypertension 2005, 45:625-630.
68. de Simone G., Devereux R.B., Roman M.J., Ganau A., Chien S., Alderman M.H., et al. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol 1991, 68:1704-1708.
69. de Simone G., Devereux R.B., Chien S., Alderman M.H., Atlas S.A., Laragh J.H. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990, 81:107-117.
70. Pickering T.G., Davidson K., Gerin W., Schwartz J.E. Masked hypertension. Hypertension 2002, 40:795-796.
71. Cioffi G., Russo T.E., Stefenelli C., Selmi A., Furlanello F., Cramariuc D., et al. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens 2010, 28:1074-1082.
72. Khouri M.G., Peshock R.M., Ayers C.R., de Lemos J.A., Drazner M.H. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging 2010, 3:164-171.
73. Aurigemma G.P., de Simone G., Fitzgibbons T.P. Cardiac remodeling in obesity. Circ Cardiovasc Imaging 2013, 6:142-152.
74. de Simone G., Devereux R.B., Chinali M., Roman M.J., Barac A., Panza J.A., et al. Sex differences in obesity-related changes in left ventricular morphology: the strong heart study. J Hypertens 2011, 29:1431-1438.
75. Nicolini E., Martegani G., Maresca A.M., Marchesi C., Dentali F., Lazzarini A., et al. Left ventricular remodeling in patients with metabolic syndrome: influence of gender. Nutr Metab Cardiovasc Dis 2012.
76. Kuch B., von Scheidt W., Peter W., Doring A., Piehlmeier W., Landgraf R., et al. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg diabetes family study. Diabetes Care 2007, 30:946-952.
77. Rider O.J., Francis J.M., Ali M.K., Byrne J., Clarke K., Neubauer S., et al. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2009, 11:9.
78. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Porcellati C. Early cardiac changes after menopause. Hypertension 1998, 32:764-769.
79. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
80. Peterson L.R., Soto P.F., Herrero P., Mohammed B.S., Avidan M.S., Schechtman K.B., et al. Impact of gender on the myocardial metabolic response to obesity. J Am Coll Cardiol Img 2008, 1:424-433.
81. Himeno E., Nishino K., Nakashima Y., Kuroiwa A., Ikeda M. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 1996, 131:313-319.
82. Alpert M.A., Terry B.E., Kelly D.L. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985, 55:783-786.
83. Karason K., Wallentin I., Larsson B., Sjostrom L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 1997, 315:912-916.
84. de Simone G., Okin P.M., Gerdts E., Olsen M.H., Wachtell K., Hille D.A., et al. Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. Nutr Metab Cardiovac Dis 2009, 19:634-640.
85. Gerdts E., de Simone G., Lund B.P., Okin P.M., Wachtell K., Boman K., et al. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Nutr Metab Cardiovasc Dis 2011, Jul 18. [Epub ahead of print].
86. de Simone G. Relationship between blood pressure and blood viscosity. Eur Heart J 1993, 14:1724-1725. [letter; comment].
87. Arcucci O., de Simone G., Izzo R., Rozza F., Chinali M., Rao M.A., et al. Association of suboptimal blood pressure control with body size and metabolic abnormalities. J Hypertens 2007, 25:2296-2300.
88. de Simone G., Devereux R.B., Izzo R., Girfoglio D., Lee E.T., Howard B.V., et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. JAHA 2013, 2(3):e000144.
89. Algahim M.F., Lux T.R., Leichman J.G., Boyer A.F., Miller C.C., Laing S.T., et al. Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med 2010, 123:549-555.
90. Rider O.J., Francis J.M., Ali M.K., Petersen S.E., Robinson M., Robson M.D., et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009, 54:718-726.
91. Viljanen A.P., Karmi A., Borra R., Parkka J.P., Lepomaki V., Parkkola R., et al. Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults. Am J Cardiol 2009, 103:1721-1726.
92. Iacobellis G., Singh N., Wharton S., Sharma A.M. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) 2008, 16:1693-1697.
93. Izzo R., de Simone G., Trimarco V., Gerdts E., Giudice R., Vaccaro O., et al. Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J 2013, in press.